872 Federal Register / Vol. 73, No. 3 / Friday, January 4, 2008 / Notices 

Form Number of 

respondents 

Responses 

per 

respondent 

Total 

responses 

Hours per 

response 

Total 

burden 

hours 

Application ............................................................................ 1800 1 1800 3 5,400 

Total ..................................................................................... 1800 ........................ 1800 ........................ 5,400 

Written comments and 

recommendations concerning the 

proposed information collection should 

be sent within 30 days of this notice to 

the desk officer for HRSA, either by email to OIRA_submission@omb.eop.gov 

or by fax to 202–395–6974. Please direct 

all correspondence to the ‘‘attention of 

the desk officer for HRSA.’’

Dated: December 27, 2007. 

Alexandra Huttinger, 

Acting Director, Division of Policy Review 

and Coordination. 

[FR Doc. E7–25604 Filed 1–3–08; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Advisory Committee on Infant 

Mortality; Notice of Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), notice is hereby given 

of the following meeting: 

Name: Advisory Committee on Infant 

Mortality (ACIM). 

Dates and Times: January 23, 2008, 9 

a.m.–5 p.m. January 24, 2008, 8:30 a.m.–

3 p.m. 

Place: Westin Washington, DC City 

Center, 1400 M Street, NW., 

Washington, DC 20005. (202) 429–1700. 

Status: The meeting is open to the 

public with attendance limited to space 

availability. 

Purpose: The Committee provides 

advice and recommendations to the 

Secretary of Health and Human Services 

on the following: Department of Health 

and Human Services’ programs that 

focus on reducing infant mortality and 

improving the health status of pregnant 

women and infants; and factors affecting 

the continuum of care with respect to 

maternal and child health care. It 

includes outcomes following childbirth; 

strategies to coordinate the variety of 

Federal, State, local and private 

programs and efforts that are designed 

to deal with the health and social 

problems impacting on infant mortality; 

and the implementation of the Healthy 

Start Program and Healthy People 2010 

infant mortality objectives. 

Agenda: Topics that will be discussed 

include the following: HRSA Update, 

MCHB Update, Healthy Start National 

Evaluation Update, presentations from a 

rural Healthy Start project and an urban 

Healthy Start project, related causes of 

infant mortality including accidents in 

the post-neonatal period, and preconceptional care. Proposed agenda 

items are subject to change as priorities 

indicate. 

Time will be provided for public 

comments limited to five minutes each; 

comments are to be submitted no later 

than January 2, 2008. 

FOR FURTHER INFORMATION CONTACT: 

Anyone requiring information regarding 

the Committee should contact Peter C. 

van Dyck, M.D., M.P.H., Executive 

Secretary, ACIM, Health Resources and 

Services Administration (HRSA), Room 

18–05, Parklawn Building, 5600 Fishers 

Lane, Rockville, MD 20857, Telephone: 

(301) 443–2170. 

Individuals who are submitting public 

comments or who have questions 

regarding the meeting and location 

should contact David S. de la Cruz, 

Ph.D., M.P.H., HRSA, Maternal and 

Child Health Bureau, telephone: (301) 

443–6332, e-mail: 

David.delaCruz@hrsa.hhs.gov. 

Dated: December 27, 2007. 

Alexandra Huttinger, 

Acting Director, Division of Policy Review 

and Coordination. 

[FR Doc. E7–25602 Filed 1–3–08; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of Meeting: Secretary’s 

Advisory Committee on Genetics, 

Health, and Society 

Pursuant to Public Law 92–463, 

notice is hereby given of the fifteenth 

meeting of the Secretary’s Advisory 

Committee on Genetics, Health, and 

Society (SACGHS), U.S. Public Health 

Service. The meeting will be held from 

8:30 a.m. to approximately 5:30 p.m. on 

Tuesday, February 12, 2008 and 8 a.m. 

to approximately 5 p.m. on Wednesday, 

February 13, 2008, at the Hubert H. 

Humphrey Building—200 Independence 

Avenue SW., Washington, DC 20201. 

The meeting will be open to the public 

with attendance limited to space 

available. The meeting also will be Web 

cast. 

The main agenda item will involve 

deliberations on the oversight of genetic 

testing, including an overview of public 

comments received on the Committee’s 

draft report U.S. System of Oversight of 

Genetic Testing: A Response to the 

Charge of the Secretary of HHS and the 

formulation of final recommendations to 

the Secretary. 

As always, the Committee welcomes 

hearing from anyone wishing to provide 

public comment on any issue related to 

genetics, health and society. Individuals 

who would like to provide public 

comment should notify the SACGHS 

Executive Secretary, Ms. Sarah Carr, by 

telephone at 301–496–9838 or e-mail at 

carrs@od.nih.gov. The SACGHS office is 

located at 6705 Rockledge Drive, Suite 

750, Bethesda, MD 20892. Anyone 

planning to attend the meeting who is 

in need of special assistance, such as 

sign language interpretation or other 

reasonable accommodations, is also 

asked to contact the Executive 

Secretary. 

Under authority of 42 U.S.C. 217a, 

section 222 of the Public Health Service 

Act, as amended, the Department of 

Health and Human Services established 

SACGHS to serve as a public forum for 

deliberations on the broad range of 

human health and societal issues raised 

by the development and use of genetic 

and genomic technologies and, as 

warranted, to provided advice on these 

issues. The draft meeting agenda and 

other information about SACGHS, 

including information about access to 

the Web cast, will be available at the 

following Web site: http:// 

www4.od.nih.gov/oba/sacghs.htm. 

Dated: December 21, 2007. 

Jennifer Spaeth, 

Director, NIH Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–6275 Filed 1–3–08; 8:45 am] 

BILLING CODE 4140–01–M 


jlentini on PROD1PC65 with NOTICES